Literature DB >> 1972320

Tourette's syndrome: a neurochemical analysis of postmortem cortical brain tissue.

H S Singer1, I H Hahn, E Krowiak, E Nelson, T Moran.   

Abstract

Postmortem frontal, temporal, and occipital regions of the brain from adult patients who had a diagnosis of Tourette's syndrome were analyzed for neurochemical alterations. In 3 of 4 TS-affected brains, the concentration of adenosine 3',5'-monophosphate (cyclic AMP) was reduced in all brain regions evaluated. This diminution in cyclic AMP was not associated with a significant change in the activity of the synthesizing enzyme, adenylate cyclase. No significant differences were identified for the neurotransmitter-synthesizing enzymes choline acetyltransferase and glutamate decarboxylase. Concentrations of dopamine, norepinephrine, and the serotonin metabolite 5-hydroxyindoleacetic acid were not altered. Postsynaptic receptor-binding activity for muscarinic cholinergic ([3H]quinuclidinyl benzilate) and beta receptors ([125I]iodocyanopindolol) showed no generalized impairment. It is suggested that symptoms of Tourette's syndrome might be related to an abnormality within a second messenger system.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1972320     DOI: 10.1002/ana.410270415

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  9 in total

Review 1.  The biochemistry of Tourette's syndrome.

Authors:  P R Chokka; G B Baker; R A Bornstein; C M de Groot
Journal:  Metab Brain Dis       Date:  1995-06       Impact factor: 3.584

Review 2.  Trace amines and Tourette's syndrome.

Authors:  G B Baker; R A Bornstein; V K Yeragani
Journal:  Neurochem Res       Date:  1993-09       Impact factor: 3.996

3.  PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome.

Authors:  N Turjanski; G V Sawle; E D Playford; R Weeks; A A Lammerstma; A J Lees; D J Brooks
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-06       Impact factor: 10.154

4.  The metabolic effects of limbic leucotomy in Gilles de la Tourette syndrome.

Authors:  G V Sawle; A J Lees; N F Hymas; D J Brooks; R S Frackowiak
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-09       Impact factor: 10.154

Review 5.  Animal models of tic disorders: a translational perspective.

Authors:  Sean C Godar; Laura J Mosher; Giuseppe Di Giovanni; Marco Bortolato
Journal:  J Neurosci Methods       Date:  2014-09-20       Impact factor: 2.390

6.  Constitutive activation of Galphas within forebrain neurons causes deficits in sensorimotor gating because of PKA-dependent decreases in cAMP.

Authors:  Michele P Kelly; Carolina Isiegas; York-Fong Cheung; Jan Tokarczyk; Xioaju Yang; Michael F Esposito; David A Rapoport; Sara A Fabian; Steven J Siegel; Gary Wand; Miles D Houslay; Stephen J Kanes; Ted Abel
Journal:  Neuropsychopharmacology       Date:  2006-05-31       Impact factor: 7.853

Review 7.  PET Neuroimaging: Insights on Dystonia and Tourette Syndrome and Potential Applications.

Authors:  Pierpaolo Alongi; Leonardo Iaccarino; Daniela Perani
Journal:  Front Neurol       Date:  2014-09-23       Impact factor: 4.003

Review 8.  Merging the Pathophysiology and Pharmacotherapy of Tics.

Authors:  Farhan Augustine; Harvey S Singer
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2019-01-09

9.  Serotonin transporter binding is increased in Tourette syndrome with Obsessive Compulsive Disorder.

Authors:  K R Müller-Vahl; N Szejko; F Wilke; E Jakubovski; L Geworski; F Bengel; G Berding
Journal:  Sci Rep       Date:  2019-01-30       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.